TY - JOUR
T1 - PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration
AU - Nagasawa, Haruo
AU - Tanji, Hiroaki
AU - Nomura, Hiroshi
AU - Saito, Hiroshi
AU - Itoyama, Yasuto
AU - Kimura, Itaru
AU - Tuji, Shoji
AU - Fujiwara, Takehiko
AU - Iwata, Ren
AU - Itoh, Masatoshi
AU - Tatsuo, Ido
PY - 1996/8
Y1 - 1996/8
N2 - We measured cerebral glucose utilization and fluorodopa metabolism in the brain of patients with corticobasal degeneration using positron emission tomography. The clinical pictures are distinctive, comprising features referable to both cerebral cortical and basal ganglionic dysfunctions. Brain images of glucose metabolism can demonstrate-specific abnormalities with a marked asymmetry in the parietal cortex (the primary motor and sensory cortex and the lateral parietal cortex); the thalamus, the caudate nucleus and the putamen of the dominantly affected hemisphere related to clinical symptoms in six patients. [18F]dopa uptake also reduced in an asymmetric pattern, both the caudate nucleus and the putamen in four patients. This unique combination study measuring both cerebral glucose utilization and fluorodopa metabolism in the nigrostriatal system can provide efficient information about the dysfunctions which are correlated with individual clinical symptoms.
AB - We measured cerebral glucose utilization and fluorodopa metabolism in the brain of patients with corticobasal degeneration using positron emission tomography. The clinical pictures are distinctive, comprising features referable to both cerebral cortical and basal ganglionic dysfunctions. Brain images of glucose metabolism can demonstrate-specific abnormalities with a marked asymmetry in the parietal cortex (the primary motor and sensory cortex and the lateral parietal cortex); the thalamus, the caudate nucleus and the putamen of the dominantly affected hemisphere related to clinical symptoms in six patients. [18F]dopa uptake also reduced in an asymmetric pattern, both the caudate nucleus and the putamen in four patients. This unique combination study measuring both cerebral glucose utilization and fluorodopa metabolism in the nigrostriatal system can provide efficient information about the dysfunctions which are correlated with individual clinical symptoms.
KW - Cerebral metabolic rate of glucose
KW - Corticobasal degeneration
KW - Dopamine metabolism
KW - Positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=0030218927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030218927&partnerID=8YFLogxK
U2 - 10.1016/0022-510X(96)00057-3
DO - 10.1016/0022-510X(96)00057-3
M3 - Article
C2 - 8856655
AN - SCOPUS:0030218927
SN - 0022-510X
VL - 139
SP - 210
EP - 217
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 2
ER -